The FDA has approved Bondlido (lidocaine topical system 10%) for the relief of pain associated with postherpetic neuralgia in adults.

Minimally invasive surgery did not significantly improve outcomes in patients with spontaneous supratentorial ICH compared with medical management alone.

Researchers associated factors with an increased risk for sudden unexpected death in epilepsy, including living alone.

NIBS may offer targeted therapeutic benefits for patients with ADHD, reducing inattention as well as hyperactivity and impulsivity symptoms.

Patients with acute ischemic stroke evaluated using telemedicine have higher odds of receiving thrombolysis treatment.

The White House has struck a deal with pharmaceutical giant Pfizer to lower the cost of prescription drugs for the Medicaid program.

A new AI tool called the PICTURE system can differentiate glioblastomas from primary central nervous system lymphoma.

Topline data were announced from a pivotal phase 1/2 study evaluating AMT-130 in patients with Huntington disease.

Skin-to-skin care duration per instance was positively associated with mean diffusivity in the cingulum and anterior thalamic radiations.

Taping the mouth shut before bed may seem like a quick fix for better sleep, but doctors are raising serious alarms about this viral trend.

The FDA has granted Fast Track designation to SAR446268 for the treatment of non-congenital myotonic dystrophy type 1.

Compared with other progestins, the use of depot medroxyprogesterone acetate is associated with an increased risk for meningioma incidence.